Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0247 per EA under NDC 49483062150. Its NADAC has been published 490 times since Feb 8, 2017.
Strength
850 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483062150
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090888On Market Since
11/14/2016
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 490 times since Feb 8, 2017, and over the history we have for it it has declined 21.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0247 per EA |
|---|---|
| All-time high | $0.0325 (Apr 12, 2017) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0282 |
| Average price | $0.0276 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 490 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0247 per EA (NDC 49483062150), effective Jun 24, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 21.8%. It has been tracked across 490 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Feb 8, 2017, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0325 (Apr 12, 2017), with a median of $0.0282 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as METFORMIN HCL 850 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 49483062150) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification